- call +1-201-465-4211
- email sales@mrinsights.biz
Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia).
Scope of the Report:
This report studies the Paronychia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Paronychia Treatment market by product type and applications/end industries.
When no pus is present, warm soaks for acute paronychia is reasonable, even though there is a lack of evidence to support its use. Antibiotics such as clindamycin or cephalexin are also often used, the first being more effective in areas where MRSA is common. If there are signs of an abscess (the presence of pus) drainage is recommended. Chronic paronychia is treated by avoiding whatever is causing it, a topical antifungal, and a topical steroid. In those who do not improve following these measures oral antifungals and steroids may be used or the nail fold may be removed surgically.
The global Paronychia Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Paronychia Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GlaxoSmithKline
Glenmark Generics
Teva Pharmaceutical Industries
Eli Lilly
Jonakayem Pharma Formulation
Fougera Pharmaceuticals
Taro Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Acute Paronychia
Chronic Paronychia
Candidal Paronychia
Pyogenic Paronychia
Market Segment by Applications, can be divided into
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Paronychia Treatment Market Overview
1.1 Product Overview and Scope of Paronychia Treatment
1.2 Classification of Paronychia Treatment by Types
1.2.1 Global Paronychia Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Paronychia Treatment Revenue Market Share by Types in 2017
1.2.3 Acute Paronychia
1.2.4 Chronic Paronychia
1.2.5 Candidal Paronychia
1.2.6 Pyogenic Paronychia
1.3 Global Paronychia Treatment Market by Application
1.3.1 Global Paronychia Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Mupirocin Ointment
1.3.3 Fusidic Acid Ointment
1.3.4 Gentamicin Ointment
1.3.5 Dicloxacillin
1.4 Global Paronychia Treatment Market by Regions
1.4.1 Global Paronychia Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Paronychia Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Paronychia Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Paronychia Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Paronychia Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Paronychia Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Paronychia Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Paronychia Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Glenmark Generics
2.2.1 Business Overview
2.2.2 Paronychia Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glenmark Generics Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Paronychia Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Industries Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Paronychia Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jonakayem Pharma Formulation
2.5.1 Business Overview
2.5.2 Paronychia Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Jonakayem Pharma Formulation Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Fougera Pharmaceuticals
2.6.1 Business Overview
2.6.2 Paronychia Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fougera Pharmaceuticals Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Taro Pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Paronychia Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Taro Pharmaceutical Industries Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Paronychia Treatment Market Competition, by Players
3.1 Global Paronychia Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Paronychia Treatment Players Market Share
3.2.2 Top 10 Paronychia Treatment Players Market Share
3.3 Market Competition Trend
4 Global Paronychia Treatment Market Size by Regions
4.1 Global Paronychia Treatment Revenue and Market Share by Regions
4.2 North America Paronychia Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Paronychia Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Paronychia Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Paronychia Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Paronychia Treatment Revenue and Growth Rate (2013-2018)
5 North America Paronychia Treatment Revenue by Countries
5.1 North America Paronychia Treatment Revenue by Countries (2013-2018)
5.2 USA Paronychia Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Paronychia Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Paronychia Treatment Revenue and Growth Rate (2013-2018)
6 Europe Paronychia Treatment Revenue by Countries
6.1 Europe Paronychia Treatment Revenue by Countries (2013-2018)
6.2 Germany Paronychia Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Paronychia Treatment Revenue and Growth Rate (2013-2018)
6.4 France Paronychia Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Paronychia Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Paronychia Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Paronychia Treatment Revenue by Countries
7.1 Asia-Pacific Paronychia Treatment Revenue by Countries (2013-2018)
7.2 China Paronychia Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Paronychia Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Paronychia Treatment Revenue and Growth Rate (2013-2018)
7.5 India Paronychia Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Paronychia Treatment Revenue and Growth Rate (2013-2018)
8 South America Paronychia Treatment Revenue by Countries
8.1 South America Paronychia Treatment Revenue by Countries (2013-2018)
8.2 Brazil Paronychia Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Paronychia Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Paronychia Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Paronychia Treatment by Countries
9.1 Middle East and Africa Paronychia Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Paronychia Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Paronychia Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Paronychia Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Paronychia Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Paronychia Treatment Revenue and Growth Rate (2013-2018)
10 Global Paronychia Treatment Market Segment by Type
10.1 Global Paronychia Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Paronychia Treatment Market Forecast by Type (2018-2023)
10.3 Acute Paronychia Revenue Growth Rate (2013-2023)
10.4 Chronic Paronychia Revenue Growth Rate (2013-2023)
10.5 Candidal Paronychia Revenue Growth Rate (2013-2023)
10.6 Pyogenic Paronychia Revenue Growth Rate (2013-2023)
11 Global Paronychia Treatment Market Segment by Application
11.1 Global Paronychia Treatment Revenue Market Share by Application (2013-2018)
11.2 Paronychia Treatment Market Forecast by Application (2018-2023)
11.3 Mupirocin Ointment Revenue Growth (2013-2018)
11.4 Fusidic Acid Ointment Revenue Growth (2013-2018)
11.5 Gentamicin Ointment Revenue Growth (2013-2018)
11.6 Dicloxacillin Revenue Growth (2013-2018)
12 Global Paronychia Treatment Market Size Forecast (2018-2023)
12.1 Global Paronychia Treatment Market Size Forecast (2018-2023)
12.2 Global Paronychia Treatment Market Forecast by Regions (2018-2023)
12.3 North America Paronychia Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Paronychia Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Paronychia Treatment Revenue Market Forecast (2018-2023)
12.6 South America Paronychia Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Paronychia Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Paronychia Treatment Picture
Table Product Specifications of Paronychia Treatment
Table Global Paronychia Treatment and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
